| Atherosclerosis and Cardiovascular Diseases | Lifetime | 156 | GB 12 | 98.73 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 268 | GB 22 | 98.68 |
| Trace Elements in Health | Lifetime | 432 | GB 33 | 97.42 |
| Antioxidant Activity and Oxidative Stress | Lifetime | 453 | GB 25 | 97.21 |
| Lipoproteins and Cardiovascular Health | Lifetime | 618 | GB 61 | 97.53 |
| Heat shock proteins research | Lifetime | 331 | GB 31 | 96.30 |
| Curcumin's Biomedical Applications | Lifetime | 153 | GB 7 | 95.52 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 756 | GB 69 | 97.58 |
| Circular RNAs in diseases | Lifetime | 847 | GB 12 | 95.63 |
| Vitamin D Research Studies | Lifetime | 583 | GB 44 | 96.25 |
| Angiogenesis and VEGF in Cancer | Lifetime | 752 | GB 48 | 95.85 |
| Lipid metabolism and disorders | Lifetime | 408 | GB 27 | 95.70 |
| Vitamin C and Antioxidants Research | Lifetime | 646 | GB 59 | 92.71 |
| Menstrual Health and Disorders | Lifetime | 299 | GB 29 | 91.06 |
| Pharmacological Effects of Medicinal Plants | Lifetime | 433 | GB 12 | 77.91 |
| Saffron Plant Research Studies | Lifetime | 429 | GB 8 | 78.32 |
| Statistical Methods in Epidemiology | Lifetime | 203 | GB 21 | 26.98 |
| MicroRNA in disease regulation | 2021-2025 | 276 | GB 1 | 96.62 |
| Cancer-related molecular mechanisms research | 2021-2025 | 567 | GB 6 | 95.60 |
| Circular RNAs in diseases | 2021-2025 | 183 | GB 2 | 95.83 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 115 | GB 5 | 92.59 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 263 | GB 13 | 93.87 |
| Nutritional Studies and Diet | 2021-2025 | 550 | GB 45 | 93.97 |
| Menstrual Health and Disorders | 2021-2025 | 44 | GB 6 | 91.73 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 498 | GB 10 | 89.16 |
| Biochemical effects in animals | 2021-2025 | 233 | GB 4 | 86.60 |
| Lipid metabolism and disorders | 2021-2025 | 176 | GB 11 | 84.62 |
| Vitamin D Research Studies | 2021-2025 | 387 | GB 28 | 84.35 |
| Curcumin's Biomedical Applications | 2021-2025 | 221 | GB 5 | 81.31 |
| Inflammatory Biomarkers in Disease Prognosis | 2021-2025 | 518 | GB 8 | 80.23 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 909 | GB 46 | 79.57 |
| Intestinal and Peritoneal Adhesions | 2021-2025 | 210 | GB 13 | 76.22 |
| Vitamin C and Antioxidants Research | 2021-2025 | 260 | GB 8 | 77.42 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 385 | GB 4 | 72.38 |
| Renal function and acid-base balance | 2021-2025 | 319 | GB 12 | 70.80 |
| Clinical Laboratory Practices and Quality Control | 2021-2025 | 562 | GB 28 | 43.63 |
| Renin-Angiotensin System Studies | 2021-2025 | 917 | GB 27 | 25.90 |
| Saffron Plant Research Studies | 2021-2025 | 681 | GB 10 | 20.65 |
| Paraoxonase enzyme and polymorphisms | 2021-2025 | 285 | GB 10 | 15.13 |
